Archito T Tamayo

Archito T Tamayo

UNVERIFIED PROFILE

Are you Archito T Tamayo?   Register this Author

Register author
Archito T Tamayo

Archito T Tamayo

Publications by authors named "Archito T Tamayo"

Are you Archito T Tamayo?   Register this Author

20Publications

204Reads

38Profile Views

Establishment and characterization of a novel MYC/BCL2 "double-hit" diffuse large B cell lymphoma cell line, RC.

J Hematol Oncol 2015 Oct 29;8:121. Epub 2015 Oct 29.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd. Unit 54, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-015-0218-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627381PMC
October 2015

In vitro and in vivo therapeutic efficacy of carfilzomib in mantle cell lymphoma: targeting the immunoproteasome.

Mol Cancer Ther 2013 Nov 29;12(11):2494-504. Epub 2013 Aug 29.

Corresponding Authors: Liang Zhang, Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 0903, Houston, TX 77030.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-13-0156DOI Listing
November 2013

Novel selective inhibitors of nuclear export CRM1 antagonists for therapy in mantle cell lymphoma.

Exp Hematol 2013 Jan 14;41(1):67-78.e4. Epub 2012 Sep 14.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2012.09.002DOI Listing
January 2013

The therapeutic effects of rGel/BLyS fusion toxin in in vitro and in vivo models of mantle cell lymphoma.

Biochem Pharmacol 2012 Aug 9;84(4):451-8. Epub 2012 Jun 9.

Immunopharmacology and Targeted Therapy Laboratory, Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2012.05.019DOI Listing
August 2012

An epigenetic chromatin remodeling role for NFATc1 in transcriptional regulation of growth and survival genes in diffuse large B-cell lymphomas.

Blood 2010 Nov 27;116(19):3899-906. Epub 2010 Jul 27.

Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2009-12-257378DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2981542PMC
November 2010

Degrasyn potentiates the antitumor effects of bortezomib in mantle cell lymphoma cells in vitro and in vivo: therapeutic implications.

Mol Cancer Ther 2010 Jul 6;9(7):2026-36. Epub 2010 Jul 6.

Department of Hematopathology, Unit 54, The University of Texas of M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-10-0238DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483974PMC
July 2010

Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting.

Blood 2009 May 19;113(19):4604-13. Epub 2009 Feb 19.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77230-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2008-10-185827DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969050PMC
May 2009

Nuclear CD40 interacts with c-Rel and enhances proliferation in aggressive B-cell lymphoma.

Blood 2007 Sep 13;110(6):2121-7. Epub 2007 Jun 13.

Department of Hematopathology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-02-073080DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976364PMC
September 2007

Nuclear localization in the biology of the CD40 receptor in normal and neoplastic human B lymphocytes.

J Biol Chem 2006 Jul 27;281(27):18878-87. Epub 2006 Apr 27.

Department of Hematopathology, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M513315200DOI Listing
July 2006

Constitutive NF-kappaB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival.

Blood 2005 Dec 11;106(12):3940-7. Epub 2005 Aug 11.

Department of Hematopathology, Box 54, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-03-1167DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1895110PMC
December 2005

Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis.

J Immunol 2003 Jul;171(1):88-95

Department of Hematopathology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.171.1.88DOI Listing
July 2003

A CD40 Signalosome anchored in lipid rafts leads to constitutive activation of NF-kappaB and autonomous cell growth in B cell lymphomas.

Immunity 2002 Jan;16(1):37-50

Department of Hematopathology, The University of Texas, M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1074-7613(01)00258-8DOI Listing
January 2002